Literature DB >> 16378661

The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data.

Lars Bertram1, Monica Hsiao, Matthew B McQueen, Michele Parkinson, Kristina Mullin, Deborah Blacker, Rudolph E Tanzi.   

Abstract

Genetic linkage studies suggest the presence of an Alzheimer's disease (AD) risk gene on chromosome 19, acting independently of apolipoprotein E (apoE), a known AD risk factor on 19q13. The low density lipoprotein receptor (LDLR) is an interesting candidate because it maps within the linked interval, and is intimately involved in cholesterol homeostasis and the function of apoE. We tested three previously reported single nucleotide polymorphisms (SNPs) within LDLR in a large sample of discordant sibships from multiplex AD families, and failed to find evidence for genetic association with disease risk. In addition, we performed meta-analyses for SNP rs5925 on published data from five independent case control samples, but did not detect any significant summary odds ratios. Based on our data, it seems unlikely that these genetic variants in LDLR make a significant contribution to AD risk in the general population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378661     DOI: 10.1016/j.neurobiolaging.2005.11.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.

Authors:  Fanggeng Zou; Rangaraj K Gopalraj; Johann Lok; Haiyan Zhu; I-Fang Ling; James F Simpson; H Michael Tucker; Jeremiah F Kelly; Samuel G Younkin; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; David A Bennett; Julia E Crook; Steven G Younkin; Steven Estus
Journal:  Hum Mol Genet       Date:  2007-12-08       Impact factor: 6.150

Review 2.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

3.  Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.

Authors:  Jungsu Kim; Joseph M Castellano; Hong Jiang; Jacob M Basak; Maia Parsadanian; Vi Pham; Stephanie M Mason; Steven M Paul; David M Holtzman
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

4.  Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

Authors:  Tricia A Thornton-Wells; Jason H Moore; Eden R Martin; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genet Epidemiol       Date:  2008-04       Impact factor: 2.135

5.  Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.

Authors:  Mario Nizzari; Stefano Thellung; Alessandro Corsaro; Valentina Villa; Aldo Pagano; Carola Porcile; Claudio Russo; Tullio Florio
Journal:  J Toxicol       Date:  2012-02-08

6.  The apolipoprotein receptor LRP3 compromises APP levels.

Authors:  Inmaculada Cuchillo-Ibañez; Matthew P Lennol; Sergio Escamilla; Trinidad Mata-Balaguer; Lucía Valverde-Vozmediano; Inmaculada Lopez-Font; Isidro Ferrer; Javier Sáez-Valero
Journal:  Alzheimers Res Ther       Date:  2021-11-02       Impact factor: 6.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.